Table 2.
Patients | NAT2 genotype | P – value | Unadjusted OR (95% CI) | Adjusted OR | |
Slow – acetylators | Rapid-acetylators | ||||
Controls (n = 140) | 62 (44.29%) | 78 (55.71%) | 1.0 (Reference) | 1.0 | |
Prostate cancer (n = 130) | 46 (35.38%) | 84 (64.62%) | 0.136 | 1.452 (0.54–1.87) | 1.348 (0.39–2.28) |
Adjusted OR = Age adjusted odds ratio.